Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
239
days
Efficacy and safety of different TPO-RAs combined with cyclosporine in the treatment of NSAA
Authors
Ting Wang; Boyi Wang; Donglan Liu; Nianbin Li; Shuai Gao; Huaquan Wang; Lijuan Li; Limin Xing; Hong Liu; Guojin Wang; Yuhong Wu; Wen Qu; Jia Song; Jing Guan; Zonghong Shao; Rong FuShow moreShow less
Affiliations
1. Department of Hematology, Tianjin Medical University General Hospital; Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hematopoietic Clone Control; Tianjin Institute of Hematology; State Key Laboratory of Experimental Hematology, Tianjin, China 117865Show moreShow less
224
days
A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns
Authors
Bing Han; Hui Liu; Guangsheng He; Jinsong Jia; Mei Hong; Jianyu Weng; Shunqing Wang; Fengkui Zhang; Ting Niu; Tianjun Ma; Jinghan Xu; Rong FuShow moreShow less
Affiliations
1. Department of Hematology, Peking Union Medical College Hospital, 12501Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; 2. Department of Hematology, 117865Tianjin Medical University General Hospital, Tianjin, China; 3. Department of Hematology, 74734Jiangsu Province Hospital, Nanjing, China; 4. Department of Hematology, 71185Peking University People’s Hospital, Beijing, China; 5. Department of Hematology, Union Hospital, Tongji Medical College, 36630Huazhong University of Science and Technology, Wuhan, China; 6. 89346Department of Hematology, Guangdong Provincial People’s Hospital, Guangzhou, China; 7. Department of Hematology, 74668Guangzhou First People’s Hospital, Guangzhou, China; 8. Institute of Hematology and Blood Diseases Hospital, 12501Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China; 9. Department of Hematology, 34753West China Hospital of Sichuan University, Chengdu, China; 10. Medical Affairs, 117754AstraZeneca China, Shanghai, ChinaShow moreShow less
345
days
Quality improvement project - Implementation of subcutaneous immunoglobulin in patients with haematological disorders and secondary immunodeficiency
Authors
Amira Chaudry; Rebecca Culpin; Shereen ElshazlyShow moreShow less
Affiliations
1. 1532Mid and South Essex NHS Foundation Trust, Broomfield Hospital, Chelmsford, UK; 2. Department of Clinical Haemato-Oncology, Ain Shams University, Cairo, EgyptShow moreShow less
238
days
Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia
Authors
Yutian Lei; Xiaoli Zhao; Huijun Huang; Limin Duan; Ji Xu; Kourong Miao; Huihui Zhao; Chun Qiao; Ming Hong; Sixuan Qian; Lei Fan; Yu ZhuShow moreShow less
Affiliations
1. Department of Hematology, Jiangsu Province Hospital, 74734The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; 2. Department of Oncology, Nanjing Second Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, ChinaShow moreShow less
330
days
Real-world efficacy and safety of the carfilzomib–pomalidomide–dexamethasone regimen in patients with relapsed/refractory multiple myeloma: A multicenter retrospective study
Authors
Huishou Fan; XiangYan Feng; Rongxia Wei; Xin Zhang; Tianlan Li; Lu Liu; Hui Wang; Lingjie Sun; Xue Shi; Hongguo Zhao; Zhao Li; Jingying Cui; Junqing Xu; Junjie Ma; Xianqi Feng; Wei WangShow moreShow less
Affiliations
1. Department of Hematology, 235960The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, China; 2. Department of Hematology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong, China; 3. 117907Department of Hematology, Weifang People’s Hospital, Weifang, Shandong, China; 4. Department of Hematology, 572575Qilu Hospital (Qingdao) of Shandong University, Qingdao, Shandong, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days